Literature DB >> 21600797

Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

Jae Jin Chae1, Young-Hun Cho, Geun-Shik Lee, Jun Cheng, P Paul Liu, Lionel Feigenbaum, Stephen I Katz, Daniel L Kastner.   

Abstract

Missense mutations in the C-terminal B30.2 domain of pyrin cause familial Mediterranean fever (FMF), the most common Mendelian autoinflammatory disease. However, it remains controversial as to whether FMF is due to the loss of an inhibitor of inflammation or to the activity of a proinflammatory molecule. We generated both pyrin-deficient mice and "knockin" mice harboring mutant human B30.2 domains. Homozygous knockin, but not pyrin-deficient, mice exhibited spontaneous bone marrow-dependent inflammation similar to but more severe than human FMF. Caspase-1 was constitutively activated in knockin macrophages and active IL-1β was secreted when stimulated with lipopolysaccharide alone, which is also observed in FMF patients. The inflammatory phenotype of knockin mice was completely ablated by crossing with IL-1 receptor-deficient or adaptor molecule ASC-deficient mice, but not NLRP3-deficient mice. Thus, our data provide evidence for an ASC-dependent NLRP3-independent inflammasome in which gain-of-function pyrin mutations cause autoinflammatory disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600797      PMCID: PMC3129608          DOI: 10.1016/j.immuni.2011.02.020

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  34 in total

1.  Treatment of familial Mediterranean fever with anakinra.

Authors:  Rakiba Belkhir; Luc Moulonguet-Doleris; Eric Hachulla; Jacques Prinseau; Alain Baglin; Thomas Hanslik
Journal:  Ann Intern Med       Date:  2007-06-05       Impact factor: 25.391

2.  Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra.

Authors:  Loes M Kuijk; Anita M A P Govers; Joost Frenkel; Willem J D Hofhuis
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

3.  The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.

Authors:  Jae Jin Chae; Geryl Wood; Seth L Masters; Katharina Richard; Grace Park; Brian J Smith; Daniel L Kastner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

Review 4.  TNFRSF1A mutations and autoinflammatory syndromes.

Authors:  J Galon; I Aksentijevich; M F McDermott; J J O'Shea; D L Kastner
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

5.  The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing.

Authors:  S Papin; S Cuenin; L Agostini; F Martinon; S Werner; H-D Beer; C Grütter; M Grütter; J Tschopp
Journal:  Cell Death Differ       Date:  2007-04-13       Impact factor: 15.828

6.  A candidate gene for familial Mediterranean fever.

Authors: 
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Cryopyrin activates the inflammasome in response to toxins and ATP.

Authors:  Sanjeev Mariathasan; David S Weiss; Kim Newton; Jacqueline McBride; Karen O'Rourke; Meron Roose-Girma; Wyne P Lee; Yvette Weinrauch; Denise M Monack; Vishva M Dixit
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

8.  Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization.

Authors:  J-W Yu; J Wu; Z Zhang; P Datta; I Ibrahimi; S Taniguchi; J Sagara; T Fernandes-Alnemri; E S Alnemri
Journal:  Cell Death Differ       Date:  2006-02       Impact factor: 15.828

9.  Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1.

Authors:  Fayyaz S Sutterwala; Yasunori Ogura; Marian Szczepanik; Maria Lara-Tejero; G Scott Lichtenberger; Ethan P Grant; John Bertin; Anthony J Coyle; Jorge E Galán; Philip W Askenase; Richard A Flavell
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

10.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations.

Authors:  H J Lachmann; B Sengül; T U Yavuzşen; D R Booth; S E Booth; A Bybee; J R Gallimore; M Soytürk; S Akar; M Tunca; P N Hawkins
Journal:  Rheumatology (Oxford)       Date:  2006-01-10       Impact factor: 7.580

View more
  165 in total

1.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 2.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 3.  Pyroptotic cell death defends against intracellular pathogens.

Authors:  Ine Jorgensen; Edward A Miao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 4.  Immunology in clinic review series; focus on autoinflammatory diseases: role of inflammasomes in autoinflammatory syndromes.

Authors:  V U Ozkurede; L Franchi
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Clinical and genetic features of hereditary periodic fever syndromes in Hispanic patients: the Chilean experience.

Authors:  Cristian Vergara; Arturo Borzutzky; Miguel A Gutierrez; Sergio Iacobelli; Eduardo Talesnik; María E Martinez; Lilith Stange; Javier Basualdo; Viviana Maluje; Renato Jimenez; Roberto Wiener; Javier Tinoco; Elena Jarpa; Juan I Aróstegui; Jordi Yagüe; Manuel Alvarez-Lobos
Journal:  Clin Rheumatol       Date:  2012-01-28       Impact factor: 2.980

Review 6.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 7.  After GWAS: mice to the rescue?

Authors:  Joerg Ermann; Laurie H Glimcher
Journal:  Curr Opin Immunol       Date:  2012-09-29       Impact factor: 7.486

Review 8.  IL-1β biological treatment of familial Mediterranean fever.

Authors:  Alessandra Soriano; Elena Verecchia; Antonella Afeltra; Raffaele Landolfi; Raffaele Manna
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 9.  Inflammatory osteolysis: a conspiracy against bone.

Authors:  Gabriel Mbalaviele; Deborah V Novack; Georg Schett; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

10.  Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction.

Authors:  Peng Xu; Zongmei Wen; Xueyin Shi; Yuehua Li; Liyan Fan; Meng Xiang; Aijun Li; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Jie Fan
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.